An important example is a new UDON-SJIA cluster dominated by IFN signaling (U12) present in patients with clinical evidence of overt and subclinical MAS, expressed by CD16+ and intermediate monocytes, pre-DCs, and other lymphocytic cell types. Here, IFNA1 is linked to macrophage activation syndrome.